Skip to Main Content

Cancer Clinical Trials

Disease Site Title Status
Breast Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer Click here for more information on this trial.
Breast Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination with Letrozole for the Treatment of Men and Pre/Postmenopausal Women with HR+ HER2- aBC Click here for more information on this trial.
Breast
A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide.

Principal Investigator: David Hufnagel, DO
Click here for more information on this trial.
Breast

Aspirin in Preventing Recurrence of Cancer in Patients with Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Prostate Registry
(Not a treatment trial)

Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) (TRUMPET)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Genetic Testing in Screening Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Crizotinib in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Nivolumab After Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer (ANVIL)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Advanced Cancers

NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.

To learn more about cancer clinical trials available, visit clinicaltrials.gov.

Cardiology Clinical Trials

Disease Site Title Status
Patients with certain kinds of Pacemakers MultiPoint Pacing™ Post Market Study (MPP-PMS)

Click here for more information on this trial.

Post MI for Diabetic and Metabolic Syndrome patients

CIRT: The Cardiovascular Inflammation Reduction Trial (CIRT)

Principal Investigator: Sridhar Vijayasekaran, MD

Click here for more information on this trial.

PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide
PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Lop

Samaritan Health Services & Oregon State University Clinical Trials

Condition Title Status
Insulin Sensitivity, Obesity and Sedentary Lifestyle

Exercise and Insulin Signaling in Human Skeletal Muscle

Samaritan Health Services Principal Investigators: Craig Graham, MD, Nicholas Phillips, MD, and Josh Lenhof, DO


Oregon State University Principal Investigators: Sean Newsom, PhD, and Matthew Robinson, PhD

Click here for more information on this trial or review an informational flyer.
Cardiac registry for student athletes Cardiovascular Screening in the Pac-12 Conference: Establishing Best Practices Click here for more information on this trial.

For more information about clinical research at Samaritan, call 541-768-4352.